The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Open accessAbstract
Despite declines in heart failure morbidity and mortality with current therapies, rehospitalization rates remain distressingly high, substantially affecting individuals, society, and the economy. As a result, the need for new therapeutic advances and novel medical devices is urgent. Disease-related left ventricular remodeling is a complex process involving cardiac myocyte growth and death, vascular rarefaction, fibrosis, inflammation, and electrophysiological remodeling. Because these events are highly interrelated, targeting a single molecule or process may not be sufficient. Here, we review molecular and cellular mechanisms governing pathological ventricular remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–268 of 268
Targeted β-Adrenergic Receptor Kinase (βARK1) Inhibition by Gene Transfer in Failing Human Hearts
Williams, M. L., Hata, J. A., Schroder, J. N., Rampersaud, E. N., Petrofski, J. A., Jakoi, A. M., Milano, C. A., & Koch, W. J. (2004) · Circulation · doi:10.1161/01.cir.0000125521.40985.28 · Cited by 112
Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure
Sabbah, H. N., Sharov, V. G., Gupta, R. C., Todor, A. V., Singh, V., & Goldstein, S. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00913-x · Cited by 105
Adipose Tissue Biology and Cardiomyopathy: Translational Implications
Turer, A. T., Hill, J. A., Elmquist, J. K., & Scherer, P. E. (2012) · Circulation Research · doi:10.1161/circresaha.111.262493 · Cited by 105
Self-citationStaudt, A., Staudt, Y., Dörr, M., Böhm, M., Knebel, F., Hummel, A., Wunderle, L., Tiburcy, M., Wernecke, K. D., Baumann, G., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.055 · Cited by 104
Bhashyam, S., Fields, A. V., Patterson, B., Testani, J. M., Chen, L., Shen, Y., & Shannon, R. P. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.900282 · Cited by 104
Targeted Anticytokine Therapy and the Failing Heart
Mann, D. L. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.007 · Cited by 103
Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study
SIMONE, G. D., Devereux, R. B., Chinali, M., Roman, M. J., Barac, A., Panza, J. A., Lee, E. T., & Howard, B. V. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347a093 · Cited by 102
Novel pharmacotherapies to abrogate postinfarction ventricular remodeling
Dorn, G. W. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.12 · Cited by 99
Inflammatory Mediators and the Failing Heart: A Translational Approach
Diwan, A., Tran, T. T., Misra, A., & Mann, D. L. (2003) · Current Molecular Medicine · doi:10.2174/1566524033361537 · Cited by 93
Anti-Inflammatory and Cardioprotective Effects of Tadalafil in Diabetic Mice
Varma, A., Das, A., Hoke, N. N., Durrant, D., Salloum, F. N., & Kukreja, R. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045243 · Cited by 92
Westermann, D., Riad, A., Lettau, O., Roks, A. J. M., Savvatis, K., Becher, P. M., Escher, F., Danser, A. H. J., Schultheiss, H., & Tschöpe, C. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.116350 · Cited by 92
Diabetic cardiomyopathy and metabolic remodeling of the heart
Battiprolu, P. K., Lopez-Crisosto, C., Wang, Z. V., Nemchenko, A., Lavandero, S., & Hill, J. A. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.10.011 · Cited by 91
Self-citationWang, Y., Sun, W., Du, B., Miao, X., Bai, Y., Xin, Y., Tan, Y., Cui, W., Liu, B., Cui, T., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00650.2012 · Cited by 90
Impact of obesity on total and cardiovascular mortality—fat or fiction?
Cepeda-Valery, B., Pressman, G. S., Figueredo, V. M., & Romero‐Corral, A. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.209 · Cited by 86
Gheorghiade, M., Albaghdadi, M. S., Zannad, F. M., Fonarow, G. C., Böhm, M., Gimpelewicz, C. R., Botha, J., Moores, S. L., Lewis, E. F., Rattunde, H., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq209 · Cited by 84
Growth factor-induced therapeutic angiogenesis in the heart: protein therapy
Annex, B. H., & Simons, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.004 · Cited by 84
Reverse remodelling in heart failure with cardiac resynchronisation therapy
Sutton, M. S.-J., & Keane, M. G. (2006) · Heart · doi:10.1136/hrt.2005.067967 · Cited by 82
Hayashi, M., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Tsutsui, T., Matsui, T., Fujii, M., Matsumoto, T., Yamamoto, T., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01539-x · Cited by 81
Novo, G., Guttilla, D., Fazio, G., Cooper, D., & Novo, S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03234.x · Cited by 80
The Immune System and Chronic Heart Failure
Fildes, J. E., Shaw, S. M., Yonan, N. A., & Williams, S. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.046 · Cited by 79
Electrical Remodeling in Cardiac Hypertrophy
Hill, J. A. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.08.002 · Cited by 77
Self-citationMuscle : fundamental biology and mechanisms of disease
Hill, J. A., Olson, E. N., Griendling, K. K., Kitsis, R. N., Stull, J. T., & Sweeney, H. L. (2012) · Cited by 76
Self-citationEpicardial epithelial-to-mesenchymal transition in injured heart
Zhou, B., & Pu, W. T. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01450.x · Cited by 76
Complement Activation in Patients With Congestive Heart Failure
Aukrust, P., Gullestad, L. L., Lappegård, K. T., et al. (2001) · Circulation · doi:10.1161/hc3801.096353 · Cited by 76
Cardiac Side Population Cells: Moving Toward the Center Stage in Cardiac Regeneration
Unno, K., Jain, M., & Liao, R. (2012) · Circulation Research · doi:10.1161/circresaha.111.243014 · Cited by 68
Packer, M. (2003) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.08.003 · Cited by 67
Wang, Y., Tandan, S., Cheng, J., Yang, C., Nguyen, L., Sugianto, J. Z., Johnstone, J. L., Sun, Y., & Hill, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803043200 · Cited by 66
Self-citationMolecular Imaging for Efficacy of Pharmacologic Intervention in Myocardial Remodeling
van den Borne, S. W. M., Isobe, S., Zandbergen, H. R., Li, P., Petrov, A. D., Wong, N. D., Fujimoto, S., Fujimoto, A., Løvhaug, D., Smits, J. F. M., et al. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.11.011 · Cited by 65
Mant, J., Al‐Mohammad, A., Swain, S., Laramée, P., & for the Guideline Development Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-4-201108160-00009 · Cited by 65
Preserved Cardiac Function After Chronic Spinal Cord Injury
de Groot, P. C., van Dijk, A. P. J., Dijk, E., & Hopman, M. T. E. (2006) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2006.05.023 · Cited by 63
Nitric Oxide Protects Against Pathological Ventricular Remodeling
Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000129569.07667.89 · Cited by 62
Therapeutic angiogenesis in the heart: protect and serve
Molin, D. G. M., & Post, M. J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.10.006 · Cited by 61
Reversibility of Adverse, Calcineurin-Dependent Cardiac Remodeling
Berry, J. M., Le, V., Rotter, D., Battiprolu, P. K., Grinsfelder, D. B., Tannous, P., Burchfield, J. S., Czubryt, M. P., Backs, J., Olson, E. N., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.228452 · Cited by 60
Self-citationPromoting angiogenesis protects severely hypertrophied hearts from ischemic injury
Friehs, I., Moran, A. M., Stamm, C., Choi, Y., Cowan, D. B., McGowan, F. X. J., & del Nido, P. J. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2003.11.003 · Cited by 59
Vascular Biomarkers in the Prediction of Clinical Cardiovascular Disease
Roman, M. J., Kizer, J. R., Best, L. G., Lee, E. T., Howard, B. V., Shara, N. M., & Devereux, R. B. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.181925 · Cited by 59
Unger, T., & Dahlöf, B. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309347792 · Cited by 59
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues
Cacciapaglia, F., Navarini, L., Menna, P., Salvatorelli, E., Minotti, G., & Afeltra, A. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.014 · Cited by 57
Pandey, K. N. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-054 · Cited by 57
Remodeling of Early-Phase Repolarization
Wang, Y., Cheng, J., Joyner, R. W., Wagner, M. B., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.615682 · Cited by 52
Self-citationGlucagon‐like Peptide‐1 and Myocardial Protection: More than Glycemic Control
Fields, A. V., Patterson, B., Karnik, A. A., & Shannon, R. P. (2009) · Clinical Cardiology · doi:10.1002/clc.20456 · Cited by 50
The aging hypertensive heart: a brief update
Sušić, D., & Frohlich, E. D. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1091 · Cited by 49
Le, T. Y. L., Mardini, M., Howell, V., Funder, J., Ashton, A., & Mihailidou, A. (2012) · HYPERTENSION · doi:10.1161/hypertensionaha.111.190488 · Cited by 49
Modification of Collagen Matrices for Enhancing Angiogenesis
Yao, C., Prével, P., Koch, S., Schenck, P., Noah, E. M., Pallua, N., & Steffens, G. C. M. (2004) · Cells Tissues Organs · doi:10.1159/000083730 · Cited by 48
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure
Rehsia, N. S., & Dhalla, N. S. (2009) · Heart Failure Reviews · doi:10.1007/s10741-009-9152-z · Cited by 47
Induction of Vascular Networks in Adult Organs: Implications to Proangiogenic Therapy
Dor, Y., Djonov, V., & Keshet, E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03224.x · Cited by 47
Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy
Mueller, E. E., Momen, A., Massé, S., Zhou, Y., Liu, J., Backx, P. H., Henkelman, R. M., Nanthakumar, K., Stewart, D. J., & Husain, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq351 · Cited by 47
The cardiac component of cardiac cachexia
Florea, V. G., Henein, M. Y., Rauchhaus, M., Koloczek, V., Sharma, R., Doehner, W., Poole-Wilson, P. A., Coats, A. J. S., & Anker, S. D. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123314 · Cited by 46
Bass, G. T., Ryall, K. A., Katikapalli, A., Taylor, B. E., Dang, S. T., Acton, S. T., & Saucerman, J. J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.009 · Cited by 46
Packer, M. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.963710 · Cited by 45
Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats
Donner, D. G., Headrick, J. P., Peart, J. N., & Toit, E. F. D. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010959 · Cited by 44
Carlsen, C. M., Bay, M., Kirk, V., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs003 · Cited by 42
Targeting Native Adult Heart Progenitors with Cardiogenic Small Molecules
Russell, J. L., Goetsch, S. C., Aguilar, H. R., Frantz, D. E., & Schneider, J. W. (2012) · ACS Chemical Biology · doi:10.1021/cb200525q · Cited by 39
Massare, J. E., Berry, J. M., LUO, X., ROB, F., Johnstone, J. L., Shelton, J. M., Bassel‐Duby, R., Hill, J. A., & Naseem, R. H. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01736.x · Cited by 38
Self-citationTaking the heart failure battle inside the cell: Small molecule targeting of Gβγ subunits
Kamal, F., Smrcka, A. V., & Blaxall, B. C. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.006 · Cited by 37
Time-Warped Comparison of Gene Expression in Adaptive and Maladaptive Cardiac Hypertrophy
Sheehy, S. P., Huang, S., & Parker, K. K. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.806935 · Cited by 34
Zhou, J., Shi, H., Zhang, J., Lu, Y., Fu, M. L. X., Ge, J., & for the β-PRESERVE Study Investigators (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp193 · Cited by 32
Epelman, S., & Mann, D. L. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9410-7 · Cited by 32
Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade
Reinkober, J., Tscheschner, H., Pleger, S. T., Most, P., Katus, H. A., Koch, W. J., & Raake, P. W. J. (2012) · Gene Therapy · doi:10.1038/gt.2012.9 · Cited by 29
Immune Modulation in Heart Failure: Past Challenges and Future Hopes
Flores‐Arredondo, J. H., García‐Rivas, G., & Torre‐Amione, G. (2011) · Current Heart Failure Reports · doi:10.1007/s11897-010-0044-2 · Cited by 27
Luzum, J. A., McLeod, H. L., Adams, K. F., & Patterson, J. H. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.01.002 · Cited by 26
Therapeutic plasma exchange a potential strategy for patients with advanced heart failure
Torre‐Amione, G., Orrego, C. M., Khalil, N., Assad‒Kottner, C., Leveque, C. M., Celis, R., Youker, K. A., & Estep, J. D. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20264 · Cited by 25
Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis
Dweck, M. R., Joshi, S., Murigu, T., Alpendurada, F., Jabbour, A., Melina, G., Banya, W., Gulati, A., Roussin, I., Raza, S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.064 · Cited by 23
Heart failure with preserved ejection fraction
Liu, Y., Haddad, T., & Dwivedi, G. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835c5492 · Cited by 23
Review: Heart failure with preserved ejection fraction in African Americans.
Shah, S. (2012) · PubMed · Cited by 18
Should a statin be prescribed to every patient with heart failure?
Tsouli, S. G., Liberopoulos, E. N., Goudevenos, J. A., Mikhailidis, D. P., & Elisaf, M. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9041-2 · Cited by 18
Gordon, O. M., Gilon, D., He, Z., May, D., Lazarus, A., Oppenheim, A., & Keshet, E. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248674 · Cited by 16
Dimas, V., Ayers, C. R., Daniels, J. D., Joglar, J. A., Hill, J. A., & Naseem, R. H. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02888.x · Cited by 13
Self-citationHuynh, H. T., Servant, N., & Chalifour, L. E. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y07-086 · Cited by 4
Cited by
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Self-citationOng, S.-B., Hernández-Reséndiz, S., Crespo-Avilan, G. E., Mukhametshina, R. T., Kwek, X.-Y., Cabrera-Fuentes, H. A., & Hausenloy, D. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.001 · Cited by 918
Physiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887
The human heart contains distinct macrophage subsets with divergent origins and functions
Bajpai, G., Schneider, C., Wong, N., Bredemeyer, A., Hulsmans, M., Nahrendorf, M., Epelman, S., Kreisel, D., Liu, Y., Itoh, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0059-x · Cited by 712
Mitochondrial dynamics, mitophagy and cardiovascular disease
Vásquez‐Trincado, C., García‐Carvajal, I., Pennanen, C., Parra, V., Hill, J. A., Rothermel, B. A., & Lavandero, S. (2016) · The Journal of Physiology · doi:10.1113/jp271301 · Cited by 629
Self-citation
Metadata
- Authors
- Burchfield, J. S., Xie, M., & Hill, J. A.
- Venue
- Circulation
- Published
- 2013-07-23
- Volume
- 128
- Issue
- 4
- Pages
- 388-400
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1968647871
- Cited by
- 766
- References
- 268
- FWCI
- 29.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.